Essex Financial Services’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $824K | Sell |
1,565
-63
| -4% | -$35.3K | 0.04% | 366 |
|
|
2026
Q1 | $915K | Buy |
1,628
+164
| +11% | +$105K | 0.05% | 311 |
|
|
2025
Q4 | $990K | Sell |
1,464
-30
| -2% | -$20.4K | 0.06% | 282 |
|
|
2025
Q3 | $955K | Buy |
1,494
+28
| +2% | +$17K | 0.06% | 280 |
|
|
2025
Q2 | $786K | Sell |
1,466
-722
| -33% | -$345K | 0.05% | 311 |
|
|
2025
Q1 | $919K | Sell |
2,188
-56
| -2% | -$24.3K | 0.07% | 247 |
|
|
2024
Q4 | $928K | Sell |
2,244
-179
| -7% | -$78.5K | 0.07% | 245 |
|
|
2024
Q3 | $1.12M | Sell |
2,423
-2
| -0.1% | -$972 | 0.08% | 215 |
|
|
2024
Q2 | $1.17M | Sell |
2,425
-25
| -1% | -$12.6K | 0.09% | 207 |
|
|
2024
Q1 | $1.32M | Sell |
2,450
-78
| -3% | -$42.6K | 0.12% | 172 |
|
|
2023
Q4 | $1.4M | Sell |
2,528
-92
| -4% | -$43.2K | 0.15% | 141 |
|
|
2023
Q3 | $1.15M | Sell |
2,620
-8
| -0.3% | -$3.99K | 0.13% | 159 |
|
|
2023
Q2 | $1.32M | Sell |
2,628
-219
| -8% | -$105K | 0.15% | 139 |
|
|
2023
Q1 | $1.42M | Sell |
2,847
-29
| -1% | -$13.9K | 0.15% | 141 |
|
|
2022
Q4 | $1.17M | Buy |
2,876
+12
| +0.4% | +$4.66K | 0.12% | 157 |
|
|
2022
Q3 | $933K | Sell |
2,864
-278
| -9% | -$102K | 0.11% | 173 |
|
|
2022
Q2 | $1.1M | Buy |
3,142
+7
| +0.2% | +$2.85K | 0.12% | 165 |
|
|
2022
Q1 | $1.72M | Buy |
3,135
+290
| +10% | +$153K | 0.16% | 131 |
|
|
2021
Q4 | $1.87M | Sell |
2,845
-2
| -0.1% | -$1.26K | 0.19% | 119 |
|
|
2021
Q3 | $1.77M | Buy |
2,847
+199
| +8% | +$134K | 0.2% | 118 |
|
|
2021
Q2 | $1.3M | Hold |
2,648
| – | – | 0.19% | 117 |
|
|
2021
Q1 | $1.3M | Sell |
2,648
-69
| -3% | -$34.6K | 0.23% | 102 |
|
|
2020
Q4 | $1.36M | Sell |
2,717
-97
| -3% | -$43.4K | 0.27% | 95 |
|
|
2020
Q3 | $1.11M | Buy |
2,814
+225
| +9% | +$83.2K | 0.27% | 89 |
|
|
2020
Q2 | $855K | Sell |
2,589
-280
| -10% | -$81.1K | 0.26% | 95 |
|
|
2020
Q1 | $695K | Sell |
2,869
-1,500
| -34% | -$391K | 0.25% | 99 |
|
|
2019
Q4 | $1.14M | Buy |
4,369
+95
| +2% | +$25K | 0.31% | 77 |
|
|
2019
Q3 | $1.16M | Buy |
4,274
+1,500
| +54% | +$417K | 0.37% | 73 |
|
|
2019
Q2 | $764K | Sell |
2,774
-100
| -3% | -$24.6K | 0.23% | 96 |
|
|
2019
Q1 | $643K | Buy |
2,874
+1,374
| +92% | +$284K | 0.19% | 112 |
|
|
2018
Q4 | $279K | Buy |
+1,500
| New | +$308K | 0.09% | 187 |
|
Other funds holding IDXX
Essex Financial Services's IDXX Position: Q2 2026 in Review
Essex Financial Services reduced its Idexx Laboratories (IDXX) stake by 3.9% in Q2 2026, selling an estimated $35.3K and leaving 1,565 shares worth $824K. The position accounts for 0.04% of the portfolio, ranked #366.
Essex Financial Services first reported a position in IDXX in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.87M in Q4 2021. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Essex Financial Services held 1,565 shares of Idexx Laboratories worth $824K as of Q2 2026.
- Essex Financial Services sold 63 Idexx Laboratories shares in Q2 2026, an estimated $35.3K.
- Idexx Laboratories made up 0.04% of Essex Financial Services's portfolio in Q2 2026, its #366 holding.
- Essex Financial Services first reported a position in Idexx Laboratories in Q4 2018 and has held it in 31 quarters since.
- Essex Financial Services's Idexx Laboratories position peaked at $1.87M in Q4 2021.
- 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Essex Financial Services's 13F filing for Q2 2026, filed 10 Aug 2026.